Is more data always better? On alternative policies to mitigate bias in Artificial Intelligence health systems
The development and implementation of Artificial Intelligence (AI) health systems represent a great power that comes with great responsibility. Their capacity to improve and transform healthcare involves inevitable risks. A major risk in this regard is the propagation of bias throughout the life cyc...
| Autori: | ; |
|---|---|
| Tipo di documento: | Elettronico Articolo |
| Lingua: | Inglese |
| Verificare la disponibilità: | HBZ Gateway |
| Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
| Pubblicazione: |
2025
|
| In: |
Bioethics
Anno: 2025, Volume: 39, Fascicolo: 5, Pagine: 414-424 |
| Notazioni IxTheo: | KBA Europa occidentale NCH Etica della medicina NCJ Etica della scienza XA Diritto YA Natural sciences |
| Altre parole chiave: | B
Artificial Intelligence Act
B medical device regulation B Bias B Artificial Intelligence B Healthcare |
| Accesso online: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
| Riepilogo: | The development and implementation of Artificial Intelligence (AI) health systems represent a great power that comes with great responsibility. Their capacity to improve and transform healthcare involves inevitable risks. A major risk in this regard is the propagation of bias throughout the life cycle of the AI system, leading to harmful or discriminatory outcomes. This paper argues that the European medical device regulations may prove inadequate to address this—not only technical but also social challenge. With the advent of new regulatory remedies, it seems that the European policymakers also want to reinforce the current medical device legal framework. In this paper, we analyse different policies to mitigate bias in AI health systems included in the Artificial Intelligence Act and in the proposed European Health Data Space. As we shall see, the different remedies based on processing sensitive data for such purpose devised by the European policymakers may have very different effects both on privacy and on protection against discrimination. We find the focus on mitigation during the pre-commercialisation stages rather weak, and believe that bias control once the system has been implemented in the real world would have merited greater ambition. |
|---|---|
| ISSN: | 1467-8519 |
| Comprende: | Enthalten in: Bioethics
|
| Persistent identifiers: | DOI: 10.1111/bioe.13398 |
